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 The venoms of Loxosceles reclusa, the brown recluse spider, and some other Loxosceles 
species cause dermonecrotic lesions—a dying of the flesh—and in severe cases, systemic injury 
and death. Since this type of injury results from a bite, diagnosis can be cryptic unless the culprit 
spider is available to be identified by an expert. The distribution of Loxosceles reclusa is also not 
well known, which further complicates diagnosis. These spiders are of additional interest 
because one of the agents in the venom is a sphingomyelinase D (SMase D) that cleaves the head 
group of sphingomyelin (SM) and causes intramolecular transphosphatidylation to produce 
ceramide 1,3-cyclic phosphate (Cer(1,3)P), a lipid that is not known to be present in humans 
otherwise. Therefore, a simple assay to analyze the presence of SMase D, by either activity 
assays or detection of its product Cer(1,3)P, could aid in identification of spider bites and 
possibly facilitate development of a treatment. A key reagent for such studies is Cer(1,3)P which 
is currently not commercially available, so we have developed a method for its synthesis and 
identified conditions for distinguishing Cer(1,3)P from the substrate SM and alternative 
hydrolysis products (ceramide-1-phosphate and ceramide) by thin-layer chromatography. The 
availability of this chemical and its synthesis procedure enables an assay of SMase D for better 
characterization of this important component of brown recluse spider venom (and possibly other 
organisms). Moreover, the assay could be used to search for enzymes that hydrolyze Cer(1,3)P, 
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Brown recluse spiders, namely Loxosceles reclusa, are often said to be responsible for the 
majority, if not all, of the necrotic wounds caused by spiders in North America.1 Brown recluse 
spiders are most highly concentrated in tropical areas of South America, and they or related 
spiders have been found worldwide, particularly in the Western Hemisphere.2 Nonetheless, there 
is an ongoing discussion2 of whether all necrotic wounds that appear in medical clinics are due to 
loxoscleism (a bite by a spider from the genus Loxosceles) because there are many cases in 
which this spider’s presence has not been documented.  
Distribution of the Loxosceles spiders is widespread, yet the exact distribution is not well 
known. Across South America, most species that are known to cause necrosis are Loxosceles 
laeta, L. intermedia, and L. gaucho, with L. laeta being the most toxic.3 Several of these species 
endemic to South America, particularly L. laeta, are shown to be larger and are thus supposed to 
have more deleterious venom than Loxosceles spiders endemic to North America.4 Loxosceles is 
not well documented across the rest of the world.  
Loxosceles spiders are nocturnal and prefer to hide in small nooks. In unnatural 
environments, Loxosceles spiders prefer mediums of construction materials, wood, and paper.5 
These spiders are characterized by their reclusive tendencies of sheltering themselves from 
humans and are known as “araña de detrás de los cuadros” (the spider behind the picture) or 
“araña de los rincones” (spider of the corners) in South America.6 
A violin pattern on the dorsal surface of the cephalothorax of Loxosceles spiders is a 
definitive method of their identification (Fig. 1).2 Problems of misidentification typically arise in 
lack of expertise. The violin pattern may perhaps be an overly simplified identifier and holds as 
an accurate identifier for most, but not all, Loxosceles spiders. A diagnostic feature that allows us 
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to better corroborate a spider’s characterization as Loxosceles is that Loxosceles spiders have six 






Figure 1. Loxosceles reclusa spider. Also known as the brown recluse or “violin spider,” 
Loxosceles reclusa has a characteristic violin-shaped patch on its cephalothorax. The spider has 









Figure 2. Anterior view of Loxosceles reclusa. This spider has a dorsal brown violin pattern 
with six eyes situated in non-touching pairs in a U-shaped pattern. The violin pattern can show 
variance among species. The eye pattern can be used as a more confident measure of 




Loxosceles2 and Sicarius7 spiders, both of the family Sicariidae, are the only spiders 
known to result in skin necrosis from spider bites. Bites commonly happen in instances in which 
the spider is pressed again the skin. Bites by Loxosceles spiders have a relatively low risk, as 
there can be as many as thousands of Loxosceles spiders in an area with no medical incidents 
reported.8  
Though toxins are of the same constituency in males and females, females carry a more 
concentrated venom.9 Spiders quite likely deliver varied amounts of venom in defensive biting, 
altering the severity of the injury from the bite.10 Amount of venom delivered also likely varies 
with prey type.   
 
Misidentification and Misdiagnosis 
Over the past few decades, bites from spiders across various genera, such as wolf spiders, 
funnel-weaving spiders, and orbweavers, have been placed under the term “necrotic 
arachnidism.”2 The majority of these identifications have been false due to lack of information 
and evidence of the culprit spider, making accurate diagnosis difficult. 
 Since common diseases can mimic spider bites, Loxosceles bites can only be identified 
with true confidence if the spider that produced the bite can be identified; otherwise the 
diagnosis may not be accurate.2 
 The most common and accurate diagnosis of spider bites is done by correctly identifying 
the spider responsible for the bite. Diseases commonly misdiagnosed as loxoscleism include 
diabetic ulcer, chemical burn, squamous cell carcinoma, syphilis, toxic epidermal necrolysis, 
Lyme disease, and anthrax.11–13 Since myriad diseases mimic loxoscleism and distribution of 
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Loxosceles spiders is not well documented, diagnosis cannot be confident if the culprit spider is 
not identified by an expert.   
 Diagnosis is hugely dependent upon proper characterization of the responsible spider; 
however, a venom test has been developed. This test uses an enzyme-linked immunosorbent 
assay (ELISA) which is an assay technique to detect and quantify peptides, proteins, antibodies, 
and hormones.14 There is no assay commercially available to humans, but in rabbits, venom was 
recoverable both form hair/skin and biopsy specimens with this assay.14  
In less serious cases, a bite by a Loxosceles spider can result in a mild urticarial reaction, 
producing swollen, pale red bumps on the skin.15 In more severe cases, the bite area turns a pale 
color, and the area adjacent to the bite turns red and edematous, with mild to severe pain (Fig. 
3).3 While the initial bite can be painless at first,3 sharp pain follows than can evolve into a 
burning sensation.16 In the days following the initial bite, the wound typically turns a blue-purple 
color and has a hard, sunken center, with sloughing occurring.3 In the most severe of cases, 
ulcers up to 40 centimeters in diameter can form and extend into deep muscles.17 
 
Figure 3. Loxosceles reclusa bite on a 
human. This is an example of a serious, 
advanced wound. The ischemia causes a 
literal dying of tissue, or necrosis, around the 
bite. Loxosceles bites are further characterized 
by dermal edema, vasodilation, hemorrhage, 
and intravascular coagulation. This image is 
from Malaque et al. (2015).18  
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Other common side effects of loxoscleism include weakness, fever, malaise, nausea, 
vomiting, thrombocytopenia, disseminated intravascular coagulation, and hemolytic anemia.3 
Renal failure can be induced by myonecrosis and rhabdomyolysis resulting from a Loxosceles 
bite.19 Loxosceles bites have been shown to result in death in South America,3 but in North 
America, there are no definitively proven deaths.20  
 
Treatment 
Currently, no effective evidence-based therapy for loxoscleism exists.2 Minimal 
treatment includes elevation, immobilization, application of ice, and local wound care. 
Additional therapies that have been used include antihistamines,14 antibiotics, dextran, 
glucocorticosteroids,21 vasodilators,22 dapsone, surgical excision, and antivenin.14 
Dapsone comes highly recommended because of the prominent role of 
polymorphonuclear (PMN) leukocytes in the pathophysiology of the injury. Dapsone has been 
shown to reduce skin lesion size in guinea pigs injected with brown recluse spider venom.23 
However, no human study shows that dapsone is an effective treatment for Loxosceles bites in 
humans.24  
Loxosceles laeta rabbit antivenom is used in South America.3,25 Antivenoms against 
Loxosceles venoms prevalent in the Americas were able to fully neutralize their respective 
venoms upon a one-hour incubation.26 Current therapies are minimally effective in treatment of 
loxoscleism, as there is a deficiency in the understanding of the mechanism(s) of Loxosceles 






The main components of the venom that are thought to be responsible for loxoscleism are 
phospholipase D (PLD) toxins which function by attacking the distal phosphodiester bond in 
phospholipids and subsequently freeing the polar head group.28,29 The prototype activity ascribed 
to the venom is a sphingomyelinase D (SMase D) that, by analogy to most PLD, would be 
expected to cleave sphingomyelin (SM) into headgroup choline and ceramide-1-phosphate 
(Cer1P) (Figs. 4 & 5). An additional activity that has been found is the release of choline from 
lysophosphatidylcholine (LPC) resulting in lysophosphatidic acid (LPA).30,31,32  
 
Figure 4. Cer1P synthesis pathways. Direct synthesis of Cer1P can occur via SMase D acting 
on SM, with choline as a byproduct. Indirect synthesis of Cer1P can occur through the activities 
of both a C-type sphingomyelinase (SMase (C)) and ceramide kinase (CerK), with a ceramide 






Figure 5. Biosynthesis of Cer1P. Starting with SM, Cer1P can be synthesized with an 
intermediate of ceramide. 
 
The enzymatic activities of Loxosceles venom include esterase,34 ATPase,35 
sphingomyelinase D,36 hyaluronidase,37 alkaline phosphatase,37 but not phospholipase A/C,35 
phosphodiesterase,38 or collagenase.35 Loxosceles venom may or may not have protease activity. 
Proteases are present in Loxosceles gastric contents and are able to cleave native collagen, 
fibrinogen, fibrin, elastin, gelatin, and fibronectin. In a rabbit model, gastric contents cannot 
cause necrosis, but it is possible that gastric contents could act with sphingomyelinase activity 
from the venom.39                   
Until recently, formation of Cer1P, and possibly LPA, were rationalized to account for 
the disruption of cell behavior because these are highly bioactive (signaling) lipids; however, 
studies of the cloned and expressed enzyme have reported that instead of the production of 
Cer1P as presumed, SMase D actually causes intramolecular transphosphatidylation to produce 
ceramide 1,3-cyclic phosphate, Cer(1,3)P (Fig. 6).40 Studies of crude Loxosceles venom have 




Figure 6. Ceramide 1,3-cyclic phosphate. Cyclic form of Cer1P, produced by the enzyme 
sphingomyelinase D.  
 
Therefore, production of Cer(1,3)P is highly likely to be a marker, and possibly even the 
cause, of the necrotic lesions associated with brown recluse spider venom. Thus, if it were 
possible to routinely assess this activity in clinical cases of necrotic wounding, it might be clearer 
if all (or most) necrotic wounding is caused by this spider. However, additional spiders could be 
involved too because comparisons of the genomes of other spiders have suggested that other 
spiders might also produce a SMase D.41 Sicarius spiders, which are in the Sicariidae family with 
Loxosceles spiders, contain PLD enzyme toxins.7  
 
Phylogeny 
Spider bites from orb-spinning spiders do not have sphingomyelinase D, and no longer 
are they deemed to cause necrosis.2 Sicarius remains the only other spider shown to contain 
significant levels of sphingomyelinase D in its venom. This spider, however, has less 
significance medically since it primarily resides in South Africa and limits human contact. The 
instance of dermonecrosis in bites has become increasingly unlikely, though, as Sicarius spiders 
have lost or significantly reduced their ability to produce sphingomyelinase D.2 Over the 
decades, the realm of necrotic bites has boiled down to loxoscleism.  
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Research in the Merrill laboratory has provided reason to believe that the Kukulcania 
hibernalis spider very likely possess sphingomyelinase D activity, evidenced by disappearance 
of SM and production of a product with a higher mobility on TLC (unpublished findings). 
However, the lack of a standard for Cer(1,3)P precluded identification of the product as Cer1P or 
the cyclic metabolite now known for the brown recluse spider venom. 
 The pathogenic bacterium Clostridium perfringens has been shown to worsen the effects 
of lesions,42 and mammalian assays of SMase D active cDNA expression products demonstrate 
that SMase D is the culprit of lesion formation.43,44 There is speculation of an evolutionary 
relationship between spider and bacterial SMase Ds.45 SMase D activity is also known in the 
pathogenic bacteria Corynebacterium pseudotuberculosis,45 C. ulcerans, Archanobacterium 
haemolyticum, and Vibrio damsela.46,47 Loxosceles, C. pseudotuberculosis, and A. haemolyticum 
SMase Ds are similar in molecular weight (30-35 kDa), isoelectric point and charge, and share 
conserved amino acid residues in the N-terminus.31,47–49 
 BLAST searches have shown the presence of homologous enzymes to SMase D in the 
fungi Aspergillus and Coccidioides,50 and this has been confirmed experimentally in A. flavus.51 
A common motif at the C-terminal end of SMase D was identified, supporting the inference 
about the origins of these enzymes stemming from the broadly conserved glycerophosphoryl 
diester phosphodiesterase family.52 By inferring that the function of the C-terminal conserved 
motif is to stabilize the internal structure of the SMase D TIM barrel, it appears that SMases D 







The goal of this study is to develop a relatively easy method to analyze Cer1P, Cer(1,3)P, 
and ceramide (Cer) to determine which products are made by different organisms, beginning 
with the brown recluse spider SMase D and eventually extending to other organisms. There are 
several reasons why this assay could be useful. A simple but analytically rigorous assay for the 
SMase D activity found in brown recluse spider venom might enable assessment of whether 
wounds that are ascribed to a bite from this spider are, indeed, associated with the presence of 
this activity. The assay could also be used to determine if other spiders have similar activity (i.e., 
the capacity to hydrolyze SM to Cer(1,3)P), and if so, this might explain why there is 
controversy over whether or not the brown recluse spider is responsible for all of the necrotic 
lesions that are clinically observed. Furthermore, if there is an association between Cer(1,3)P and 
necrotic lesions, an assay for Cer(1,3)P might facilitate development of a treatment to remove 
this product (such as an enzyme that would cleave one or both ester bonds) to decrease the extent 












METHODS AND MATERIALS 
Sources of Reagents 
 All of the sphingolipids (C12- and C24- Cer and Cer1P) and fluorescent analogs (NBD-
Cer, NBD-Cer1P, and NBD-SM) were obtained from Avanti Polar Lipids (Alabaster, Alabama). 
The C24-Cer(1,3)P was synthesized from C24-Cer1P by modification of a published method53 
(see below). 
The HPLC-grade organic solvents (chloroform, # EM-CX1050 and methanol, # EM-
MX0475) were obtained from VWR (West Chester, PA); ACS grade acetic acid (# A38C-212) 
was obtained from Fischer (Pittsburg, PA); and all other solvents were analytical grade. N,N’-
dicyclohexylcarbodiimide and iodine were from Sigma-Aldrich (St. Louis, MO). The thin-layer 
chromatography (TLC) plastic sheets (Silica gel 60) were from EM Science (Darmstadt, 
Germany). 
The SMase D from recluse spider venom was obtained via Chuck Kristensen at Spider 
Pharm (Yarnell, Arizona). 
 
Pilot Synthesis of Cer(1,3)P 
A pilot synthesis of Cer(1,3)P was conducted following the reaction conditions described 
by Boudker and Futerman53 for the synthesis of C6-NBD-Cer(l,3)P. It was conducted using C12- 
(lauroyl-) and C24- (lignoceroyl-) CerlP (Avanti) (~1 mol) incubated with a 1.5-fold molar 
excess of N,N'-dicyclohexylcarbodiimide (DCCD) in 2 mL of N,N-dimethylformamide in 13 x 
100 mm glass screw-capped test tubes with a saturated atmosphere of N2. The mixture was 
turbid, so the reaction time was increased to 4 days (instead of 1-2 days) at room temperature, 
with sonication, as well as heating the tube under warm water, to attempt to bring all of the 
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reactants into solution (this appeared to help, but the mixture was always somewhat cloudy). 
Afterward, the N,N-dimethylformamide was dried under a stream of N2, and the products were 
dissolved in chloroform and methanol (2:1, v/v) and extracted with essentially as described by 
Bligh and Dyer.54 The solvents from the product extraction were removed under a stream of N2, 
redissolved in 0.5 mL of chloroform and methanol (2:1, v/v), and aliquots were examined by 
TLC on silica gel plates using chloroform:methanol:acetic acid:15 mM aqueous CaCl2 
(60:35:2:4, v/v/v/v) as the developing solvent. After the solvents had dried, the plate was placed 
in a tank with saturating I2 vapor for several hours to visualize the hydrophobic compounds, and 
then the plate was examined. Based on Boudker and Futerman,53 the Rf for Cer(1,3)P should be 
higher than starting Cer1P and would be predicted to be below the unreacted DCCD and 
byproduct N,N'-dicyclohexylurea. 
 
Optimized Synthesis of Cer(1,3)P 
 After testing several solvents as alternatives for DMF, pyridine was selected as the best 
because it has been used in other DCCD coupling papers, and all of the reagents for this 
synthesis were readily soluble in it. In addition, since C24-Cer1P was readily soluble in pyridine 
and was available in larger quantity, the subsequent synthesis was conducted with it alone.  
Approximately 1 mol of C24-CerlP (Avanti) in pyridine was mixed with another 0.5 mL of 
pyridine containing ~2 mol of DCCD in a screw-capped test tube, then the air was replaced by 
N2, and the reaction mixture was left for 2 days at room temperature with gentle rocking. 
Afterwards, the pyridine was dried under a stream of N2 and the products were dissolved in 
chloroform and methanol (2:1, v/v) and extracted with essentially as described by Bligh and 
Dyer.54 The solvents from the product extraction were removed under a stream of N2, redissolved 
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in 0.5 mL of chloroform and methanol (2:1, v/v), and aliquots were examined by TLC using the 
optimized TLC conditions that had been established empirically (see below), and the 
components were visualized using iodine vapor. 
 
Purification of Cer(1,3)P by Silica Gel Column Chromatography 
 The Cer(1,3)P was separated from most of the other components of the reaction mixture 
by silica gel column chromatography with elution by chloroform and increasing proportions of 
methanol. The silica gel (Supelco) was suspended in chloroform and added rapidly to a small 
glass column (ca. 1 cm in width x 6 cm in height) with a glass frit until the settled bed of silica 
gel was approximately 3 cm in height. Then, the column was washed with several mL of 
chloroform and drained until the solvent reached the top of the column. Examination of the 
eluate showed that silica was not leaking through the frit, so without allowing the solvent to run 
dry at the top of the column, the reaction products (dissolved in ~ 0.5 mL of chloroform) were 
loaded to the column and washed in with several mL of additional chloroform. Fractions of 
approximately 3 mL each were collected in glass test tubes from the time that the reaction 
mixture was added to the column. In each step, 6 mL of the following solvent mixtures 
(chloroform with increasing % methanol) were added to the top of the column (with care not to 
disturb the silica) and the eluate from each collected in two test tubes; the % methanol were 0%, 
1%, 5%, 25% and 50%.* Once all of the column fractions had been collected, the solvents were 
removed under a stream of N2 with the test tubes in a tepid water bath, and then the contents 
were redissolved in 0.5 mL of chloroform:methanol (1:1, v/v). Aliquots from each of these tubes 
were spotted onto a silica gel TLC, along with standards and developed by the optimized TLC 
 
* A better separation was later achieved by adding the methanol percentages 15% and 20%. 
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conditions that had been established empirically (see below), and the components were 
visualized using iodine vapor.  
 The TLC analysis revealed that the putative Cer(1,3)P appeared in the 25% methanol 
eluates, which also contained smaller amounts of Cer1P based on co-elution with the starting 
Cer1P and the intensity of the iodine staining. There was no contamination by the other major 
iodine-positive species (DCCD and N,N'-dicyclohexylurea), which eluted from the column 
earlier. To confirm that the major, higher Rf compound that appeared in the 25% methanol 
eluates was Cer(1,3)P, the material in these two test tubes was pooled and an aliquot 
(representing ~ 50 to 100 g of Cer(1,3)P assuming > 50% of the starting Cer1P was converted 
to this product) was submitted to Dr. David Bostwick in the mass spectrometry core in the Petit 
Institute for Bioengineering and Biosciences for analysis by liquid chromatography-high 
resolution mass spectrometry.  
 
TLC Optimization 
 The initial TLC conditions that were used had previously been reported to separate C6-
NBD-Cer1P and C6-NBD-Cer(1,3)P,53 which are more polar than the synthesized C24- species; 
therefore, both C24-Cer1P and C24-Cer(1,3)P migrated very high on the plate (Rf  > 0.5). Thus, 
alternative solvents were tested to achieve better separation of the synthesis products. These 
solvents had varied components (using various combinations of two or more of the following: 
chloroform, methanol, acetic acid, water, and 2N ammonium hydroxide) in different ratios. The 
two best solvents for separation of C24-Cer1P and C24-Cer(1,3)P (and the corresponding C24-
SM) were CHCl3:methanol:H2O:acetic acid (60:20:2:1, v/v/v/v) and CHCl3:methanol:H2O 
(60:20:2, v/v/v). Both of these solvents were accordingly used to analyze the synthetic products, 
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column eluates, and venom assay samples when the C24-sphingolipids were involved. It was 
noted that the substitution of ammonium hydroxide for acetic acid caused a large shift in the Rf 
of the C24-Cer1P (to nearly the same position as for SM) but not the Cer(1,3)P. This observation 
is consistent with the expected chromatographic behavior of Cer1P having a second dissociable 
hydroxyl with a pKa that would enable it to be dianionic under these conditions.  
 
Incubation of SMase D from Brown Recluse Spider Venom with SM 
 This assay was conducted with two substrates: C6-NBD-SM, which had been used by Dr. 
Merrill’s previous students, and C24-SM, which has the advantage that there are now standards 
for the anticipated cyclic product from the synthesis described above. For the incubation, each 
assay contained 10 mM MgCl2 and 100 mM Tris-HCl (pH 7.5), the SM substrate, and an 
uncertain quantity of SMase D from brown recluse spider venom (probably on the order of 
several ng, but the quantity was too low to assay) versus water for the no enzyme control. Since 
the SM requires a detergent to solubilize it, Triton X-100 and β-decyl-glucopyranoside were 
considered, and the latter was rejected because its Rf on TLC was too close to the SM. Both 
types of SM were highly soluble in Triton X-100, so substrate stocks were prepared at 1 mM (for 
C6-NBD-SM or C24-SM) with 1 mM Triton X-100, and these were diluted into the assay 
mixture for a final concentration of 100 M.   
 The assay was conducted in 100 µL with half of the assay volume comprised of the 
SMase D and/or water and the rest for buffers and substrate. These tubes were capped and 
incubated in a dark 37 °C water bath overnight.   The reaction products were extracted by 
organic solvents (CHCl3:MeOH, 1:2, v/v), dried under a stream of N2, and then redissolved in 
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 No statistical analysis was conducted because the interruption of laboratory work at the 
pilot stage did not allow time to conduct the final assays in replicates. Therefore, the findings 




















The first step of this project was to prepare Cer(1,3)P, the reported40 product of the action 
of the brown recluse SMase D on SM, because this reagent is not currently available 
commercially. The published method53 for synthesis of a fluorescent analog, C6-NBD-Cer(1,3)P, 
was not found to be successful because the Cer1P with natural N-acyl chains was not sufficiently 
soluble in DMF, even when a relatively short chain length (i.e., C12-) was used. However, this 
problem was solved by our finding that Cer1P is highly soluble in pyridine, which is another 
solvent that is often used for DCCD coupling reactions. The results of this reaction are presented 
below. The results are only described qualitatively because it was not possible to conduct enough 
replicate reactions to calculate a percentage yield due to the closing of the research laboratories 
mid-semester. Indeed, this was the case for all of the findings in this report; however, there were 
several clear deliverables from the work because we identified a reaction solvent (as mentioned) 
and found a TLC system that could separate Cer1P and Cer(1,3)P (as well as SM and Cer) for 
analysis of the synthetic reaction and for assays of SMase D. In addition, a preliminary 
experiment with brown recluse spider venom appeared show that it produced the cyclic 
phosphate, but this needs confirmation and quantitation. These results are described in more 
detail in the following subsections. 
 
TLC Separation Conditions 
Since there is not a method for separation of C24-Cer1P and C24-Cer(1,3)P has not been 
reported, we tried several variations of the protocol for separation of the NBD- analogs. These 
variations consisted of CHCl3:MeOH:HOAc:15 mM CaCl2 (60:20:1:2, v/v/v/v),
53 and we found 
that simpler mixtures of chloroform, methanol, and either water alone or with acetic acid 
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(CHCl3:MeOH:H2O:HOAc, 60:15:2:1, v/v/v/v and CHCl3:MeOH:H2O, 3:1:0.1, v/v/v) were 
effective. Table 1 shows the Rf values for these compounds and SM and Cer under these 
conditions.  
 
Table 1. Rf values of Cer1P, Cer(1,3)P, SM, and Cer under various solvent conditions. A 
general trend, going from the bottom to the top of the TLC plate, appears to be SM, Cer1P, 
Cer(1,3)P, and then Cer resting closest to the top.  
 
Column Chromatography Conditions 
 Column chromatography of the reaction products from synthesis of C24-Cer(1,3)P from 
C24-Cer1P using DCCD in pyridine was conducted as described under Methods. The unreacted 
DCCD eluted in the early fractions (chloroform and 1% methanol, not shown), whereas, the 
putative C24-Cer(1,3)P and unreacted C24-Cer1P eluted with 25% methanol (test tubes #10 and 
11) as shown in Fig. 7.  
  
CHCl3:MeOH:HOAc:15 mM CaCl2 
60:20:1:2, v /v /v /v
CHCl3:MeOH:H2O:HOAc 
60:15:2:1, v /v /v /v
CHCl3:MeOH:H2O 
3:1:0.1, v /v /v
C24-Cer(1,3)P 0.44 0.46 0.48
C24-Cer1P 0.34 0.28 0.19
C24-SM * 0.06 0.12
C12-NBD-SM * 0.06 0.16
C12-NBD-Cer * 0.95 0.93









Figure 7. Compounds eluted from a silica gel column by 25% 
methanol in chloroform. Products from the synthesis of C24-
Cer(1,3)P were applied to a small silica column as described 
under Methods, and the fractions were examined by TLC with 
development by CHCl3:MeOH:H2O, 3:1:0.1, v/v/v.  
Test tube         #  9  10  11  12 
% MeOH           5   25   25  50 
 
 A second column included intermediate methanol percentages, and C24-Cer(1,3)P was 
seen to elute in the test tubes for 15% and 20% MeOH. Therefore, a slight modification of this 
elution protocol should be able to get better separation of the Cer(1,3)P and unreacted Cer1P. 
 
Evaluation of the Success of the Synthesis of Cer(1,3)P Synthesis in Pyridine 
 As can be seen in Fig. 7, the putative Cer(1,3)P was the darkest iodine staining material 
in test tube #10 (> 75% of the total) and appeared to be slightly darker or equal to Cer1P in test 
tube #11. Overall, the putative Cer(1,3)P in test tube #11 appeared to account for > 50% of the 
iodine staining; therefore, the reaction yield was at least that high.   
 To confirm that this material was Cer(1,3)P, an aliquot of the material in test tube #10 
was analyzed by high resolution mass spectrometry. The negative ionization mode spectrum is 
shown in Fig. 8 and the structure and exact mass of C24-Cer(1,3)P is shown in Fig. 9 for 









Figure 8. High resolution mass spectrum of sample #10 in negative ionization mode. 
 
 
Figure 9. Chemical structure and exact mass of C24-Cer(1,3)P. This drawing and the 
calculated exact mass were prepared using ChemDraw Professional 16.0. 
 
The major ion at m/z 710.5850 (Fig. 8) is consistent with the calculated exact mass of 
deprotonated Cer(1,3)P (i.e., M minus H+ = 710.5858) (c.f., Fig. 9). In addition, the spectrum 
shows a minor peak at m/z 1422.1769 which is consistent with the predicted m/z for dimeric 
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Cer(1,3)P monoanion (i.e., 2 x M - H+ = 1422.1789) (would be expected because lipids tend to 
form dimers in electrospray ionization MS). 
 Therefore, the identity of the C24-Cer(1,3)P was verified by mass spectrometry, and its 
migration position on TLC versus C24-Cer1P could be used to determine which product is 
produced by the brown recluse SMase D or other similar enzymes produced by other organisms. 
 
Pilot Assay of Brown Recluse SMase D and Identification of the Product 
 Using the assay conditions described under Methods, C24-SM was incubated with 
purified SMase D from brown recluse spider venom and examined by TLC, as shown in Fig. 10. 
Although the photographic images are hard to see, it appeared to the eye that iodine staining was 
present in the regions for the substrate SM and the product Cer(1,3)Ps for the SMase D incubated 
tubes (Enz). The location of the Cer(1,3)P was established by the co-spotting with the synthetic 
column fractions #10 (which had only Cer(1,3)P) and #11 (which had Cer(1,3)P and Cer1P).   
 
Figure 10. TLC of the lipid extracts after 
incubation of C24-SM with SMase D. The 
assays were conducted as described under 
Methods with the TLC plate developed with 
CHCl3:MeOH:H2O (3:1:0.1, v/v/v). “Enz” is the 
SMase D tube, “+Std” is the co-spotting of 
“Enz” with standards (column ftns #10 and 11). 




 The purified SMase D from brown recluse spider venom was also incubated with NBD-
SM as described under Methods, but the fluorescence was too faint for conclusions to be drawn. 
These analyses will need to be repeated and quantified, but the preliminary observations are 
























The goal of this study was to develop a relatively easy method to analyze Cer(1,3)P to be 
able to determine with certainty when this product was made by SMase Ds from different 
organisms. Our plan was to begin with the brown recluse spider SMase D and eventually extend 
the method to other organisms.   
The method was TLC-based since it does not require sophisticated instrumentation, and 
at least the fluorescent analogs (NBD) SM, Cer1P, and Cer(1,3)P had been separated by TLC in 
two previous studies.40,53 But a limitation was the lack of a Cer(1,3)P standard to optimize and 
validate the method. That problem has now been solved, and when it is possible for work to 
continue in the lab, we will apply it to venoms from Loxosceles and other spiders. 
Previous studies by students in Dr. Merrill's laboratory have identified that several other 
spiders have detectable SM hydrolytic activity in venom: Kukulcania spp. (YAAZ), Larinioides 
spp. (BVAZ), Latrodectus tredecimguttatus, Psalmopoeus cambridgei, and Pterinochilus spp. 
(Usambara). Therefore, it is important to determine if they produce the same SMase D product as 
Loxosceles venom (i.e., Cer(1,3)P) or perhaps the product of mammalian sphingomyelinases and 
other enzymes (i.e., Cer1P and/or Cer).  
This could be significant clinically if the production of Cer(1,3)P is a possible cause of 
dermonecrotic lesions. Since Loxosceles bites are quite difficult to accurately assess at the 
moment, especially if the culprit spider is not available to be identified by an expert, this assay 
could help to alleviate the identification problem somewhat. We could also find that perhaps not 
all necrotic wounding possesses SMase D activity. Ultimately, this assay would hopefully lead to 
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